SG Americas Securities LLC bought a new position in Exponent, Inc. (NASDAQ:EXPO - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 8,209 shares of the business services provider's stock, valued at approximately $665,000.
Several other institutional investors have also made changes to their positions in EXPO. Private Trust Co. NA boosted its holdings in shares of Exponent by 129.8% during the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock worth $25,000 after purchasing an additional 157 shares during the period. Atala Financial Inc purchased a new position in Exponent during the fourth quarter valued at approximately $25,000. Whipplewood Advisors LLC lifted its stake in Exponent by 5,333.3% in the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock valued at $26,000 after acquiring an additional 320 shares during the last quarter. Tortoise Investment Management LLC lifted its stake in Exponent by 76.7% in the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after acquiring an additional 191 shares during the last quarter. Finally, Brown Brothers Harriman & Co. acquired a new stake in Exponent in the fourth quarter valued at approximately $50,000. 92.37% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Exponent
In related news, VP Bradley A. James sold 2,694 shares of the company's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total transaction of $214,226.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Joseph Rakow sold 1,573 shares of the company's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The disclosure for this sale can be found here. Over the last three months, insiders sold 6,267 shares of company stock worth $489,120. 1.60% of the stock is owned by insiders.
Exponent Trading Down 2.9%
NASDAQ EXPO traded down $2.17 during trading on Friday, reaching $72.88. The company's stock had a trading volume of 851,592 shares, compared to its average volume of 255,594. The stock has a market capitalization of $3.70 billion, a PE ratio of 35.55 and a beta of 0.92. The business has a 50-day moving average price of $77.50 and a 200-day moving average price of $83.82. Exponent, Inc. has a 1-year low of $72.83 and a 1-year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. The firm had revenue of $137.44 million during the quarter, compared to analysts' expectations of $134.63 million. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The company's revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.59 earnings per share. As a group, analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend was Friday, June 6th. Exponent's payout ratio is 58.54%.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.